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Abstract
Hepatitis C virus (HCV) belonging to the family Flaviviridae has infected 3% of the population worldwide and 6% of
the population in Pakistan. The only recommended standard treatment is pegylated INF-a plus ribavirin. Due to
less compatibility of the standard treatment, thirteen medicinal plants were collected from different areas of
Pakistan on the basis of undocumented antiviral reports against different viral infections. Medicinal plants were air
dried, extracted and screened out against HCV by infecting HCV inoculums of 3a genotype in liver cells. RT-PCR
results demonstrate that acetonic and methanolic extract of Acacia nilotica (AN) showed more than 50% reduction
at non toxic concentration. From the above results, it can be concluded that by selecting different molecular
targets, specific structure-activity relationship can be achieved by doing mechanistic analysis. So, additional studies
are required for the isolation and recognition of antiviral compound in AN to establish its importance as antiviral
drug against HCV. For further research, we will scrutinize the synergistic effect of active antiviral compound in
combination with standard PEG INF-a and ribavirin which may be helpful in exploring further gateways for antiviral
therapy against HCV.
Background
HCV is a global health problem annually affecting 180
million people worldwide [1]. Approximately 10 million
(6% of the population) individuals are affected from
HCV in Pakistan [2]. More than 60% of acutely infected
patients turned out to be chronically infected [3]. HCV
belongs to the family Flaviviridae which is enveloped
viruses harboring positive-sense single-stranded RNA
genome [4,5]. Whole viral genome is 9.6 kb nucleotides
long encoding a large polyprotein precursor, which is
cleaved by several viral and cellular proteases into differ-
ent structural and non structural proteins (NS) [4,5].
Structural proteins (Core, E1, E2 and probably p7) are
proteolytically slashed from the N-terminal segment of
the viral polyprotein by cellular signal peptidases [6-8].
NS proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B)
are formed at the NS2-NS3 intersection by the NS2-3
metalloprotease and at the downstream position of NS3
by the NS3 serine protease [9-13].
The current standard therapy of HCV infection is
pegylated interferon-a (PEG-IFN) combined with riba-
virin which is recommended for 24-48 weeks depending
upon viral genotype [14]. Current therapeutic options
for hepatitis C are limited, especially for genotype 1. For
genotypes 2 and 3, PEG INF-a plus ribavirin, can lead
to a sustained virological response in up to 80% of
patients [15]. In some races, response rates were still
lower, with rates of approximately 25 to 30% among
blacks [16]. Higher doses and prolonged therapy leading
to the transient virologic response was associated with
increased side-effects [17]. Hemolytic anemia is the
most common side-effects of ribavirin, which has terato-
genic effects [18]. Therefore, innovative, more valuable
and less toxic agents are vital for HCV treatment.
HCV is becoming a serious world problem which causes
acute and chronic HCV infection. Some botanical consti-
tuents such as glycyrrhizin, catechin, silymarin, phytoster-
ols, the antioxidants N-acetylcysteine and vitamin E were
assessed for their efficiency in curing chronic hepatitis and
liver damage [19]. Therapeutic herbal extracts such as Bos-
wellia carterii, Embelia schimperi, Piper cubeba, Quercus
infectoria, Trachyspermum ammi and Syzygium aromati-
cum were investigated in-vitro for their antiviral activity
against HCV protease [20]. Natural products could be
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[21]. Recently, five patients with chronic hepatitis C were
treated for 1 year with Viscum album extract. The yield in
HCV production was reduced about 6-20-fold in two
patients along with stabilization of liver function,
enhanced life worth and diminutive serious side effects
[22]. Extract of Agaricus blazei Murill (AbM) are utilized
comprehensively as a non-prescription therapy against
cancer and infections, including hepatitis. The viral stack
was faintly, but not drastically, lessened after 1 week of
AbM treatment [23]. A diverse group of plants has been
identified promisingly lowering the HCV-RNA below
detection level such as cyclosporin A [24], 2-arylbenzo-
furan derived from Mori cortex radicis, as NS3 helicase
inhibitor [25], Mellein, a compound extracted from the
fungus Aspergillus ochraceus, reveals anti-HCV protease
activity with an IC50 value of 35 μmol/L [26]. Therefore,
natural plants showing antiviral activity against HCV
could mark new prospects by further analysis and
improvement. Various antiviral compounds possess much
higher chemical assortment and biochemical precision
than standard combined chemistry. Such compounds put
forward foremost prospect for identifying potent struc-
tures showing antiviral activity against various targets.
In present study, we have documented AN as antiviral
agent against HCV genotype 3a. Thirteen medicinal
plants were collected from different areas of Pakistan.
These plants were extracted in different solvents and
screened out against HCV by doing real time quantifica-
tion and identified AN as novel antiviral agent against
HCV.
Materials & methods
Serum Sample collection
HCV-3a patient’ss e r u ms a m p l e su s e di nt h i si n v e s t i g a -
tion were obtained from the CAMB (Center for Applied
Molecular Biology) diagnostic laboratory, Lahore, Paki-
stan. Serum samples were stored at -80°C prior to viral
inoculation experiments. Quantification and genotype
was assessed by CAMB diagnostic laboratory, Lahore,
Pakistan. Patient’s written consent and approval for this
study was obtained from institutional ethics committee.
Extraction of Medicinal plants
Thirteen different plants were collected and dried on the
basis of their medicinal characteristics. These indigenous
plants were collected from different climatic zones of
Pakistan. The plant species were correctly identified by
Department of Botany, University of the Punjab, Lahore.
Plants were dried under shade at room temperature.
Dried parts of plants were macerated in blender, then
weighed and poured methanol for overnight. Tempera-
ture should never exceed 38°C which is favorable for
enzymatic activity. After 24 h solvents were filtered,
residue was soaked again in methanol. Filtration was
repeated over 3-4 days. Methanolic extract was further
partitioned in chloroform, acetone and n-hexane.
Solvents were selected on the basis of polarity for the
prelude characterization of antiviral compounds.
Extracts were weighed and calculating their percentage
yield (data not shown).
Stock solution preparation
50 mg of each dried plant extract was suspended in 1
ml of Dimethyl sulfoxide (DMSO) ensuing stock con-
centration of 50 μg/μl. Sieving the above solutions by
using 0.22 um filter inside Laminar Flow Hood and
stored at -20°C.
Cell lines
The Huh-7 cell line was offered by Dr. Zafar Nawaz
(Biochemistry and Molecular Biology Department, Uni-
versity of Miami, USA). Huh-7 cells were cultured in
Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 10% fetal bovine serum & 100 IU/ml peni-
cillin & 100 μg/ml streptomycin, at 37°C in an
atmosphere of 5% CO2.
MTT Assay for Toxicity
To investigate the cellular toxicity, 2 × 10
4 cells/well was
plated into 96-well plates. After 24 h, different concen-
trations of Herbal extracts were added and the plate was
sealed and kept at 37°C in an atmosphere of 5% CO2 for
24 h. After completion of extraction, media and test
compounds were removed. 100 μl fresh media and 20 μl
of MTT solution (5 mg/ml in PBS) were added to all
wells in Columns 1-11. Wrapped the plate in aluminium
foil and incubated for 3-4 h at 37°C. Media was carefully
removed and added 100 μl of DMSO to dissolve the for-
mazan crystals in Columns 1-11. MTT formazan pro-
duct was determined by measuring absorbance with an
enzyme-linked immunosorbent assay (ELISA) plate
reader at a test wavelength of 570 nm and a reference
wavelength of 620 nm.
Cell viability was obtained using the following equation.
Percent cell viability = (Test 570nm − 620nm/Control 570nm − 620nm) ∗ 100
Anti-HCV analysis of plant extracts on Huh-7 cells
Huh-7 cell line was used to establish the in-vitro repli-
cation of HCV. A similar protocol was used for viral
inoculation as established by Zekari et al. 2009 [27] and
El-Awardy et al. 2006 [28]. High viral titer > 1 × 10
8
IU/ml from HCV patients of 3a genotype was used as
principle inoculum in these experiments. Huh-7 cells
were maintained in 6-well culture plates to semi-conflu-
ence, washed twice with serum-free medium, then
Rehman et al. Virology Journal 2011, 8:220
http://www.virologyj.com/content/8/1/220
Page 2 of 6inoculated with 500 μl( 5×1 0
7IU/well) serum media
and 500 μl serum free media. Cells were maintained
o v e r n i g h ta t3 7 ° Ci n5 %C O 2. Next day, adherent cells
were washed three times with 1× PBS, complete med-
ium was added and incubation was continued for
48 hrs. Cells were harvested and assessed for viral RNA
quantification by Real Time PCR. To analyze the effect
of medicinal plant extracts on HCV, serum infected
Huh-7 cells were again seeded after two days of infec-
tion in 24-well plates in the presence and absence of
herbal extracts and grown to 80% confluence with 2 ml
medium. After 24 h, cells and total RNA was isolated by
using Gentra RNA isolation kit (Gentra System Pennsyl-
vania, USA) according to the manufacturer’si n s t r u c -
tions. Briefely, cells were lysed with cell lysis solution
containing 5 μl internal control (Sacace Biotechnologies
Caserta, Italy). RNA pallet was solubilized in 1% DEPC
(Diethyl pyrocarbonate treated water). HCV RNA quan-
tifications were determined by Real Time PCR Smart
Cycler II system (Cepheid Sunnyvale, USA) using the
Sacace HCV quantitative analysis kit (Sacace Biotechnol-
ogies Caserta, Italy) according to the manufacturer’s
instructions.
Formula for the calculation of HCV RNA concentration
Following formula was used to calculate the concentra-
tion HCV RNA of each sample.
Cy3STD/Res
Fam. STD/Res
× coefﬁcient IC = IU HCV/mL
IC = internal control, which is specific for each lot
Results
Thirteen medicinal plants were collected from different
areas of Pakistan on the basis of undocumented reports
for antiviral screening against HCV. Plants materials
were air dried and extracted in methanol. All informa-
tion regarding botanical names, family vernacular names
and local uses of 13 medicinal plants were shown in
Table 1.
Cellular Toxicity through MTT cell proliferation assay
Before starting the antiviral screening against Hepatitis
C virus, toxicological effects of thirteen plant extracts
were determined through MTT proliferation assay. The
MTT substance is reduced by mitochondrial succinic
dehydrogenases in living cells to purple formazan crys-
tals that are not soluble in aqueous water. The absorp-
tion of dissolved formazan in the visible region
correlates with the number of alive cells [29]. Figure 1
exhibited cytotoxic effects of AN and demonstrated that
cell proliferation of liver cells is unaffected up to a con-
centration of 100 μg. Similar results were observed for
additional 12 medicinal extracts ranging from a concen-
tration of 1 to 100 μg.
Antiviral activity of methanolic extract of AN against HCV
infected liver cells
Several reports have documented that human hepatocyte
cultures can be infected with HCV serum [30]. Solvent
extracts from different plants were tested to determine
the antiviral activity against HCV. Real time RT-PCR
results showed that AN out of 13 medicinal plants
exhibited antiviral effects against HCV. The results
demonstrated that AN resulted in 27% inhibition of
HCV RNA at non toxic concentration (Figure 2). This
extract was further fractionated in different solvents on
the basis of polarity.
Characterization of methanolic extract of AN in different
solvents
Further, methanolic extract of AN was fractionized by
different solvents such as hexane and acetone based
upon their polarity content. Results have revealed that
acetone extract of an impeded viral titer to greater
extent than methanolic extract at a concentration of
50 μg (Figure 3).
Discussion
The significant prevalence of HCV infection, lack of virus-
specific treatment and less compatibility of authenticated
therapy suggest in exploring the medicinal plants with the
aim of seeking suitable antiviral compounds. Although,
agents presently in progress that target NS5B polymerase
and NS3-4A protease show dominant inhibitory behavior
yet all those drugs illustrate an elevated propensity for
resistance sprouting. To control this dilemma, other
impending viral targets need to be discovered.
In present study, we aimed at investigating antiviral
compounds against HCV to identify potential bioactive
agents. Thirteen plant extracts and fractions were scruti-
nized for their antiviral activity against HCV. A rudi-
mentary acetonic extract of AN leaves showed evidence
of exhibiting antiviral activity at a concentration of
100 μg against HCV RNA expression when evaluated
via real time RT-PCR.
A lot of Acacia species have also been accounted to be
useful against an array of diseases including malaria, sore
throat (aerial part) and toothache (bark) [31]. Antifungal
efficacy of Acacia nilotica, commonly called babul, have
been reported recently on animals where zone of inhibi-
tion was 7.62 mm at the end of 48 h by using bark of tree
containing significant amount of antimicrobial agents [32].
Significant chemopreventive and antimutagenic activity of
the leaf extract of Acacia nilotica, on 7,12 dimethylbenz(a)
anthracene (DMBA) stimulated skin papillomagenesis in
male Swiss albino mice was demonstrated followed by the
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natural antioxidant, possessing free radical scavenging
activity. Ethanolic extract of AN rich in phenolic and fla-
vonoid contents exhibiting persuasive antioxidant activity.
The methanol extract of AN bark revealed the existence
of Alkaloids, glycosides, tannins and phenolics which can
explain its higher free radical scavenging activity and can
be employed as supplement to assist the therapy of free
radical induced diseases such as cancer, diabetes, inflam-
mation, etc [34].
Prior to the appraisal of antiviral activity of selected
plants, cell viability effects on Huh-7 cells were evalu-
ated. For this rationale, cell counting and MTT calori-
metric assay was employed by incubating serially diluted
extracts along with Huh-7 cells. The results of cytotoxi-
city assessment of effective extract by using above men-
tioned assays found non toxic dose at a concentration of
100 μg as shown in Figure 1.
Table 1 List of selected Pakistani Medicinal plants
Botanical
Name
Common Name Family Local uses
Withania
coagulans
Paneer dodi Solanaceae Remedy for dyspepsia, flatulent colic, intestinal diseases.
Tamarix
gallica
Tamarisk, jhavuka Tamaricaceae Used in bleeding disorders like menorrhagia, epistaxis
Tinospora
cordifolia
Guduchi, Tinospara,
Giloy
Meninspermaceae antipyretic, alterative, diuretic, anti-inflammatory
Berberis
aristata
Daruhaldi, Rasvat,
Maramanjal
Berberidaceae Antimalarial, remedy for ophthalmia
Raphanus
sativus
Radish, Daikon Brassicaceae As carminative, diuretic, expectorant, laxative and stomachic. Remedy for asthma and other
chest complaints
Terminalia
Chebula
Myrobalan, Hardad Combretaceae An effective purgative and helps in removing toxins and fats from the body
Fumaria
officinalis
Fumitory, Earth
smoke
Fumariaceae Treatment for arthritis, liver disorders and gallstones, acts as a diuretic, slightly diaphoretic,
aperient, a tonic, a digestive and as an infusion used externally in the treatment of scabies
Kalanchoe
laciniata
Christmas tree Crassulaceae As topicals for ulcer, headache, emollient
Eclipta
erecta
False daisy, Bringraj Asteraceae For jaundice and other ailments of the liver, spleen and gall bladder, shows antifungal
activity
Citrullus
vulgaris
Water melon Cucurbitacea For dropsy and hepatic congestion and intestinal catarrh
Rheum
Emodi
Himalayan Rhubarb,
Revat Chinni
Polygonaceae As purgative and astringent tonic, strong laxative.
Piper nigrum Black Pepper,
Peppercorns
Piperaceae For the treatment of pain relief, rheumatism, chills, flu, colds, increase circulation,
exhaustion, muscular aches, nerve tonic and fevers
Acacia
nilotica
Babul, Scented-pod
Acacia
Fabaceae Bark as a cough remedy, to treat eye diseases, or as a tranquillizer and even as an
aphrodisiac
Figure 1 Toxicity of extract of AN: Huh-7 cells were incubated at
different concentrations of the herbal extracts. At the end of
incubation period, absorbance readings were taken through
microplate sepectrophotometer
Figure 2 Anti-HCV activity of methaolic extract AN: Huh-7 cells
were incubated with HCV serum and 100 μg concentration of the
for 24 h. At the end of incubation period, total RNA was extracted
by Gentra kit, and the levels of HCV RNA remaining were
determined by the Quantitative RT-PCR assay and are shown as a
percentage relative to the levels of HCV RNA in cells incubated
without compound (control).
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doable to substantiate strong antiviral activity against
HCV. However, fractionation of methanolic extract of
AN leaves into different solvents leads to the further
specification of in-vitro antiviral activity of extract.
Acetonic extract of AN leaves illustrated 82% inhibition
of viral titer as compared to methanolic extract exhibit-
ing 73% decrease in the viral RNA expression as com-
pared to control lacking extract, as explained by the
Figure 2a and 2b. Hexane fraction of AN leaves demon-
strated only 7% reduction of viral titer. Results suggested
the direct inactivation of HCV by using acetonic AN
extract.
Natural products which are biologically dynamic in
different assays are usually small molecules having both
drug-like characteristics and capability of being
absorbed. So the cost of formulating such medicine is
much lower than that of producing from combinatorial
chemistry [35]. Recently, silymarin and its two fractions
(S1 and S2) are found to inhibit HCV core gene of 3a
genotype and its combinational therapy with interferon
will be a better option for HCV patients [36]. Globally,
varieties of herbal plants have been extensively used as
curative for various infectious diseases. But there is still
an entailment for the identification and acquaintance of
molecular targets, antiviral compound metabolism and
structure-activity correlation, for engendering the med-
icinal plants more effectual. More importantly, it seems
that auxiliary explorations are obligatory in order to
depict solid conclusion.
Abbreviations
HCV: Hepatitis C virus; AN Acacia nilotica; PEG-INF: Pegylated interferon;
Huh-7: Human Hepatoma Cell line.
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